Related references
Note: Only part of the references are listed.
Article
Medicine, General & Internal
Michael Mueller et al.
Summary: This study compared the early immune responses to AZD1222 and BNT162b2 vaccines, and found that the strategy for spike protein delivery affects the immune priming against the main SARS-CoV-2 antigen.
Article
Biochemistry & Molecular Biology
Alison Tarke et al.
Summary: T cell responses induced by different vaccine platforms cross-recognize early SARS-CoV-2 variants, while memory B cells and neutralizing antibodies show significant decreases. The majority of memory T cell responses are preserved against variants, with lower recognition of Omicron by memory B cells.
Article
Biochemistry & Molecular Biology
Philip A. Mudd et al.
Summary: SARS-CoV-2 mRNA vaccines induce potent immune responses, including antibodies and CD4(+) T cell responses. Research has found that vaccine-induced follicular helper CD4(+) T cell responses play a key role in establishing long-term immunity.
Article
Microbiology
Sara Terreri et al.
Summary: This study investigated the long-term and functional B cell memory induced by the BNT162b2 mRNA vaccine against SARS-CoV-2 in healthcare workers. While specific antibodies declined over time, memory B cells persisted and increased, and breakthrough infections did not show signs of waning immunity.
CELL HOST & MICROBE
(2022)
Article
Multidisciplinary Sciences
Wooseob Kim et al.
Summary: SARS-CoV-2 mRNA vaccination induces a persistent germinal center reaction in humans, resulting in affinity-matured long-term antibody responses that potently neutralize the virus.
Article
Multidisciplinary Sciences
Sarah Adamo et al.
Summary: Researchers used spectral flow cytometry combined with cellular indexing of transcriptomes and T cell receptor sequencing to longitudinally characterize individual SARS-CoV-2-specific CD8(+) T cells from patients with COVID-19, identifying a distinct signature marking long-lived memory CD8(+) T cells. The study found that SARS-CoV-2-specific memory CD8(+) T cells persisting 1 year after acute infection express specific markers and exhibit characteristics resembling effector memory T cells, and that certain transcriptional signatures and signaling pathways are associated with the fate of individual clones of these cells.
Review
Biotechnology & Applied Microbiology
Yuan Tian et al.
Summary: This review summarizes existing studies using single-cell technologies to investigate the immune responses and molecular mechanisms in COVID-19. Understanding the immune cell subsets and molecular factors associated with protective or pathological immunity may contribute to the development of vaccines and therapeutics for COVID-19. Single-cell technologies show promise in uncovering the heterogeneity of immune responses and pathogenesis mechanisms of COVID-19.
NATURE BIOTECHNOLOGY
(2022)
Review
Immunology
Paul Moss
Summary: T cell immunity plays a central role in controlling SARS-CoV-2 infection, with early responses correlating with protection. T cell memory provides broad recognition of viral proteins, limiting the impact of viral variants and offering protection against severe disease. Current COVID-19 vaccines elicit robust T cell responses, contributing to the prevention of hospitalization or death. Therefore, the importance of T cell immunity may have been underestimated.
Article
Immunology
R. Camille Brewer et al.
Summary: This study investigated the B cell response to the BNT162b2 vaccine by integrating B cell repertoire analysis with single-cell transcriptomics pre- and post-vaccination. It found that the first vaccine dose generated a recall response of IgA(+) plasmablasts targeting the S subunit S2, while the second dose strongly boosted this response and produced potent neutralizing antibodies against SARS-CoV-2 and its variants.
Article
Immunology
Anna H. E. Roukens et al.
Summary: Systemic immune cell dynamics during COVID-19 have been well-documented, but less is known about immune cells in the respiratory tract. This study characterized nasal and systemic immune cells in COVID-19 patients, showing increased inflammatory cells in the nasal mucosa during acute infection. After recovery, nasal immune cells mostly normalized, but SARS-CoV-2-specific CD8(+) T cells could persist for at least 2 months.
Article
Biochemistry & Molecular Biology
Sarthak Sinha et al.
Summary: New findings illuminate the molecular mechanisms of dexamethasone action in severe COVID-19 patients, highlighting the expansion of distinct neutrophil states and altered immune dynamics. These results pave the way for the development of targeted immunotherapies for severe COVID-19 by defining COVID-19-enriched neutrophil states and the molecular mechanisms of dexamethasone action.
Review
Immunology
Dhakshayini Morgan et al.
Summary: This review discusses the importance of single cell technologies in assessing the genomics, transcriptomics, and proteomics of individual B cells. Understanding B cell development, differentiation, antibody repertoire, and responses during homeostasis, infection, and disease can lead to the identification of different B cell gene signatures and biomarkers, with potential benefits for future therapeutic discoveries.
TRENDS IN IMMUNOLOGY
(2022)
Article
Multidisciplinary Sciences
Avraham Unterman et al.
Summary: Using multi-omics single-cell analysis, this study reveals the immune abnormalities associated with progressive COVID-19, including S100A(hi)/HLA-DRlo classical monocytes and activated LAG-3(hi) T cells. It also finds a correlation between T cell receptor repertoire and B cell somatic hypermutation frequency with disease progression.
NATURE COMMUNICATIONS
(2022)
Article
Multidisciplinary Sciences
Carlo Cervia et al.
Summary: By studying the immunoglobulin signature of COVID-19 patients and combining it with factors such as age, history of asthma, and symptoms during the primary infection, the risk of post-acute COVID-19 syndrome (PACS) can be predicted independently of the timepoint of blood sampling.
NATURE COMMUNICATIONS
(2022)
Article
Immunology
Gang Xu et al.
Summary: COVID-19 patients exhibit heterogeneous and dynamic immune features, which have an impact on the clinical outcome. The immune landscape in severe COVID-19 patients fluctuates greatly, while it remains relatively stable in asymptomatic/mild cases. After recovery, the perturbed immune landscape returns to normal state.
FRONTIERS IN IMMUNOLOGY
(2022)
Editorial Material
Biochemistry & Molecular Biology
Stuart G. Tangye et al.
Summary: This review article investigates the establishment of effective and long-lasting immunity against SARS-CoV-2, with a focus on the physiological birthplace of adaptive immunity - the germinal centers, as well as the characteristics of systemic and local humoral immune responses following natural infection or vaccination with SARS-CoV-2.
Correction
Biochemistry & Molecular Biology
Vivek Naranbhai et al.
Article
Biochemistry & Molecular Biology
Lauren B. Rodda et al.
Summary: Research found that individuals previously infected with SARS-CoV-2 generate more specific memory B cells, variant-neutralizing antibodies, and a distinct population of memory CD4(+) T cells compared to those who were previously naive. Additional vaccination does not replicate the unique CD4(+) T cell cytokine profile observed in previously infected individuals.
Article
Immunology
Aurelien Sokal et al.
Summary: The Omicron variant of SARS-CoV-2 is able to escape neutralization by antibodies elicited by vaccines and previous infection. However, the memory B cells (MBCs) generated by mRNA vaccines can still recognize and neutralize the Omicron variant to some extent, providing a certain level of protection for vaccinated individuals.
Article
Multidisciplinary Sciences
Frauke Muecksch et al.
Summary: Receiving three doses of an mRNA vaccine can provide protection against the Omicron variant and induce the production of more potent and broader antibodies. This is due to the expansion and evolution of memory B cell clones, particularly the newly emerging clones that target more conserved regions.
Article
Immunology
Kathleen M. Wragg et al.
Summary: Wragg and colleagues tracked clonal populations of spike-specific CD4(+) cT(FH) cells using MHC class II tetramers and TCR beta sequencing in convalescent individuals with COVID-19 or SARS-CoV-2-vaccinated individuals. They found that both infection and vaccination induced CD4(+) T cell responses to the spike protein and that these responses correlated with neutralizing antibodies. Secondary exposure led to the recall of CD4(+) T cells with a transitory CXCR3(+) phenotype and expansion of cT(FH) cells temporarily expressing ICOS, CD38, and PD-1. The study demonstrates that stable pools of cT(FH) and memory CD4(+) T cells established by infection and/or vaccination can be efficiently recalled and may contribute to long-term protection against SARS-CoV-2.
Article
Immunology
Anastasia A. Minervina et al.
Summary: Thomas and colleagues explore the impact of multiple SARS-CoV-2 antigen exposures on T cell immunity. They find that vaccination after infection leads to expansion of spike-specific T cells, while individuals after breakthrough infection mount vigorous non-spike-specific responses. They also observe that all exposures elicit diverse T cell immune repertoires, with no evidence of repertoire narrowing from repeated exposure.
Article
Infectious Diseases
Li Guo et al.
Summary: This study investigated the durability and functionality of the humoral and T-cell response to the original SARS-CoV-2 strain and variants in recovered patients 12 months after infection. The results showed that neutralising antibodies and T-cell responses were retained 12 months after initial infection. However, the neutralising antibody responses to the D614G, beta, and delta variants were reduced compared to the original strain, while T-cell responses were cross-reactive to the beta variant. This suggests that cross-reactive T-cell responses may be particularly important in protecting against severe disease caused by variants, while neutralising antibody responses seem to diminish over time.
Article
Multidisciplinary Sciences
Kevin J. Kramer et al.
Summary: Through the analysis of multiple single-cell technologies, researchers have identified antigen-specific cells and antibody responses to the RNA vaccine BNT162b2, which is crucial for understanding the immune mechanisms of RNA vaccines.
NATURE COMMUNICATIONS
(2022)
Article
Multidisciplinary Sciences
Aloysious Ssemaganda et al.
Summary: This study investigates T cells in the nasal mucosa and blood after vaccination with the Pfizer-BioNTech COVID-19 vaccine. The results show an increase in tissue-resident memory CD8(+) T cells expressing CD69(+)CD103(+) in the nasal mucosa after the first and second doses, while CD69(+)CD103(+)CD8(+) T cells in the blood decrease post-vaccination. There is also an increase in nasal CD8(+)CD69(+)CD103(-) T cells, particularly following the second dose. Additionally, CD4(+) cells co-expressing CCR6 and CD161 are increased in abundance following both doses. Stimulation of nasal CD8(+) T cells with SARS-CoV-2 spike peptides elevates expression of CD107a and cytokines.
NATURE COMMUNICATIONS
(2022)
Review
Immunology
Brian J. Laidlaw et al.
Summary: The GC response is crucial in establishing durable and broad immunity against SARS-CoV-2, with emerging evidence suggesting new approaches to modulate GC response and long-term immune responses induced by vaccines. Importantly, GC B cell responses persist for at least 6 months in some individuals following SARS-CoV-2 vaccination.
NATURE REVIEWS IMMUNOLOGY
(2022)
Review
Biochemistry & Molecular Biology
Alessandro Sette et al.
Summary: The adaptive immune system, consisting of B cells, CD4(+) T cells, and CD8(+) T cells, plays varying roles in different viral infections and vaccines. Studies are showing that CD4(+) T cells, CD8(+) T cells, and neutralizing antibodies all play a part in controlling SARS-CoV-2 in COVID-19 cases, emphasizing the importance of understanding adaptive immunity in combating the disease.
Article
Cell Biology
Els Wauters et al.
Summary: Single-cell deep-immune profiling revealed that specific T cells in mild COVID-19 patients exhibit active expansion and function, while in critical COVID-19 they remain more naive. Furthermore, the monocyte-to-macrophage trajectories show enrichment of chronic hyperinflammatory monocytes and depletion of anti-inflammatory alveolar macrophages in critical COVID-19.
Article
Cell & Tissue Engineering
Anna Maria Ranzoni et al.
Summary: Using single-cell RNA sequencing and single-cell assay for transposase-accessible chromatin sequencing, researchers identified three highly proliferative oligopotent progenitor populations downstream of hematopoietic stem cells (HSCs)/multipotent progenitors (MPPs) in human fetal liver and bone marrow. They observed dynamic changes in chromatin accessibility and lineage-specific transcription factor activity along the differentiation trajectory, providing a useful framework for future investigation of human developmental hematopoiesis.
Article
Immunology
Min-Seok Rha et al.
Summary: Memory T cell responses have been observed in COVID-19 convalescents, with specific T cells showing different phenotypes during the recovery phase. SARS-CoV-2-specific CD8(+) T cells displayed early differentiated effector-memory phenotypes in the early convalescent phase and an increased proportion of stem-like memory cells in the late convalescent phase. Compared to influenza A virus-specific CD8(+) T cells, SARS-CoV-2-specific CD8(+) T cells had a lower frequency of IFN-gamma-producing cells. Additionally, PD-1-expressing SARS-CoV-2-specific CD8(+) T cells were functional rather than exhausted.
Review
Biochemical Research Methods
Shenghao Guo et al.
Summary: Single-cell metabolomics is a powerful tool for high-throughput metabolic analysis at the cellular level, with great potential in decoding cell heterogeneity and identifying cell types within colonies. The development of various equipment and techniques has made SCM analysis possible for a wide range of biological samples, leading to fruitful findings in various fields such as phytology, neurology, and oncology.
CURRENT OPINION IN BIOTECHNOLOGY
(2021)
Article
Cell Biology
Nils H. Wildner et al.
Summary: This study utilized 16-color flow cytometry analysis to investigate peripheral B cells in patients with SARS-CoV-2 infection or acute Plasmodium falciparum malaria. The results showed an increase in atypical memory B cells and plasmablasts in these patients, along with changes in specific protein expression on the plasmablasts. These changes were positively correlated with inflammatory markers in COVID-19 patients.
JOURNAL OF LEUKOCYTE BIOLOGY
(2021)
Review
Immunology
Oreste Gallo et al.
Summary: This study critically reviews the latest molecular and cellular findings on the mucosal response to SARS-CoV-2 in the nasal cavity and in NALT, and analyzes its impact on the subsequent course of COVID-19. The possibility of modulating the systemic inflammatory network against the virus starting from the initial phases of the nasal and nasopharyngeal response is explored, with potential clinical and epidemiological implications for mucosal vaccine development.
MUCOSAL IMMUNOLOGY
(2021)
Article
Multidisciplinary Sciences
Alexis J. Combes et al.
Summary: Patients with mild COVID-19 exhibit a coordinated pattern of expression of interferon-stimulated genes (ISGs) across every cell population, whereas these ISG-expressing cells are systemically absent in patients with severe disease. Individuals with severe COVID-19 produce very high titres of anti-SARS-CoV-2 antibodies and have a lower viral load compared to individuals with mild disease.
Article
Multidisciplinary Sciences
Christian Gaebler et al.
Summary: After infection with SARS-CoV-2, antibody levels against the spike protein decrease significantly, but the number of memory B cells remain unchanged, indicating an evolving humoral response at 6.2 months after infection.
Article
Biochemistry & Molecular Biology
Aurelien Sokal et al.
Summary: Memory B cells play a crucial role in host defense against SARS-CoV-2, with distinct B cell clone responses to the virus contributing to long-lasting immune protection. The study also highlights the significance of somatic mutations in the variable region genes of memory B cells over time, indicating continued maturation and long-term immune memory post-infection.
Article
Biochemistry & Molecular Biology
Xianwen Ren et al.
Summary: The study revealed the presence of immune response dysfunction in COVID-19 patients, with different peripheral immune subtype changes associated with clinical features such as age, sex, severity, and disease stages. Additionally, dramatic transcriptomic changes were observed within virus-infected cells, and upregulation of S100A8/A9 in peripheral blood may contribute to the cytokine storms frequently observed in severe patients.
Article
Immunology
Peter A. Szabo et al.
Summary: This study investigated the immune responses in the respiratory tract and blood of severe COVID-19 patients, revealing that T cells in the airways showed protective profiles while myeloid cells exhibited hyperinflammatory signatures. These findings provide important insights for understanding and treating COVID-19 lung pathology.
Article
Multidisciplinary Sciences
Alice Cho et al.
Summary: Infection with SARS-CoV-2 leads to evolving B cell responses over at least a year, while vaccination with mRNA vaccines results in high plasma neutralizing activity against various variants. Memory B cells from vaccinated individuals show increased neutralizing activity between prime and boost, but do not exhibit further expansion in potency or breadth.
Editorial Material
Biochemistry & Molecular Biology
Jennifer A. Juno et al.
Article
Multidisciplinary Sciences
Pierre Bost et al.
Summary: COVID-19 patients show unique immune features, including lung accumulation of naive lymphoid cells, systemic expansion and activation of myeloid cells, and immune suppression. Loss of monocyte-driven and neutrophil-driven immune suppression may lead to fatal outcomes in severe patients. On the other hand, a lung CXCR6(+) effector memory T cell subset may be associated with better prognosis in severe COVID-19 patients.
NATURE COMMUNICATIONS
(2021)
Article
Immunology
Yu Zhao et al.
Summary: Hyperinflammation contributes to lung injury in severe COVID-19, with T-RM 17 cells identified as potential orchestrators of this process. High levels of IL-17A and GM-CSF were associated with a more severe clinical course in patients with COVID-19.
SCIENCE IMMUNOLOGY
(2021)
Article
Cell Biology
Kathryn A. Pape et al.
Summary: Infection-induced primary MBCs have better antigen-binding capacity and generate more plasmablasts and secondary MBCs compared to vaccine-induced primary MBCs. These results suggest that infection-induced primary MBCs have undergone more affinity maturation and produce more robust secondary responses.
Article
Immunology
Laura Bergamaschi et al.
Summary: The kinetics of immune changes in COVID-19 across different severity groups show that early bystander CD8(+) T cell immune response is prominent in asymptomatic or mild diseases, while severe cases have persistent cellular abnormalities and immune defects, which may increase clinical risks.
Article
Immunology
Gisella Guerrera et al.
Summary: Vaccination with the Pfizer-BioNTech mRNA vaccine induces a sustained anti-viral T cell response for at least 6 months, demonstrating immunological competence and long-term memory against SARS-CoV-2.
SCIENCE IMMUNOLOGY
(2021)
Article
Medicine, Research & Experimental
Suhas Sureshchandra et al.
Summary: mRNA vaccines for SARS-CoV-2 have shown strong protection against severe disease, enhancing spike-specific B cells and robust CD4(+) T cell responses. However, CD8(+) T cell responses following vaccination were relatively weak and variable, with clonally expanded CD8(+) T cells observed.
Article
Biochemistry & Molecular Biology
Emily Stephenson et al.
Summary: Transcriptomic and proteomic profiling of blood samples from individuals with COVID-19 reveals immune cell and hematopoietic progenitor cell alterations that are differentially associated with disease severity.
Article
Multidisciplinary Sciences
Anastasia Gangaev et al.
Summary: This study identified a range of SARS-CoV-2 CD8(+) T cell responses across COVID-19 patients, including an epitope from ORF1ab with immunodominant features. The specific CD8(+) T cell responses can still be detectable up to 5 months after recovery from critical and severe disease, converting from dysfunctional effector cells to functional memory cells during convalescence.
NATURE COMMUNICATIONS
(2021)
Article
Biochemistry & Molecular Biology
Vyshnavie R. Sarma et al.
Summary: This study utilized immunoinformatics algorithms to model potential B- and T-cell epitopes in the S protein of SARS-CoV-2, selecting epitopes with high potentials to trigger immunogenic responses.
BIOMEDICAL JOURNAL
(2021)
Article
Immunology
Sunil Kumar Saini et al.
Summary: This study experimentally evaluated MHC class I-binding peptides covering the complete SARS-CoV-2 genome, revealing significant CD8(+) T cell recognition of SARS-CoV-2 epitopes in patients with COVID-19, coupled with strong activation features in these T cells. Compared to healthy individuals, patients with severe disease displayed larger populations of SARS-CoV-2-specific T cells.
SCIENCE IMMUNOLOGY
(2021)
Review
Microbiology
Alba Grifoni et al.
Summary: This review summarizes recent studies on SARS-CoV-2 T cell epitopes, highlighting the significant correlation between epitope number and antigen size. It also presents an analysis of 1,400 different reported SARS-CoV-2 epitopes and identifies discrete immunodominant regions of the virus and more prevalently recognized epitopes.
CELL HOST & MICROBE
(2021)
Review
Immunology
Xin Wang et al.
Summary: The application of multiomic technologies has greatly advanced the research on the virology, immunology, and pathogenic mechanisms of SARS-CoV-2 infection, effectively aiding the development of new diagnostics, drugs, and vaccines.
CELLULAR & MOLECULAR IMMUNOLOGY
(2021)
Article
Immunology
Aurelien Sokal et al.
Summary: This study examined the MBC responses in recovered and naive individuals after mRNA vaccination against SARS-CoV-2, finding that the MBC pool in recovered individuals expanded selectively, matured further, and had potent neutralizers against VOCs. Naive individuals displayed weaker neutralizing serum responses, but a significant portion of their RBD-specific MBCs showed high affinity to multiple VOCs, suggesting potential efficient response to VOCs in naive vaccinees.
Article
Multidisciplinary Sciences
Jackson S. Turner et al.
Summary: The study found that individuals who had recovered from mild SARS-CoV-2 infections showed rapid decline of serum anti-SARS-CoV-2 spike protein antibodies in the first 4 months after infection, followed by a more gradual decrease over the following 7 months but remaining detectable at least 11 months after infection. This suggests that mild infection with SARS-CoV-2 can induce robust antigen-specific, long-lived humoral immune memory in humans.
Article
Multidisciplinary Sciences
Prabhu S. Arunachalam et al.
Summary: The study found that vaccination with the Pfizer-BioNTech mRNA vaccine can induce immune responses against neutralizing antibodies and CD4, CD8 T cells of SARS-CoV-2. Booster vaccines can significantly enhance innate immune responses, and different innate pathways associated with CD8 T cells and neutralizing antibodies have been identified.
Article
Multidisciplinary Sciences
Jackson S. Turner et al.
Summary: SARS-CoV-2 mRNA vaccines induce a persistent germinal centre B cell response in humans, leading to the generation of robust humoral immunity, especially more significant in individuals previously infected with the virus.
Article
Multidisciplinary Sciences
Valerie Oberhardt et al.
Summary: After vaccination, CD8(+) T cells become important effector cells in providing early protection, being effectively mobilized one week after primary vaccination and maintaining stability after booster vaccination. Compared with natural infection, vaccine-induced CD8(+) T cells exhibit similar functional capacities but with a different subset distribution.
Article
Multidisciplinary Sciences
Zijun Wang et al.
Summary: Despite challenges posed by COVID-19 variants, convalescent individuals receiving mRNA vaccines exhibit robust and long-lasting immune responses against circulating SARS-CoV-2 variants, providing hope for effective control of the pandemic.
Article
Multidisciplinary Sciences
Ugur Sahin et al.
Summary: The BNT162b2 vaccine shows 95% efficacy in preventing COVID-19 by boosting neutralizing antibody titres and activating specific T cell responses. The vaccine-induced immune response is broad and stable, lasting for a prolonged period, providing good coverage against various SARS-CoV-2 variants.
Article
Multidisciplinary Sciences
Massimo Andreatta et al.
Summary: The authors successfully established reference T cell atlases for cancer and viral infection by integrating multiple studies and developing ProjecTILs algorithm. It accurately predicts cell perturbations effects and identifies highly conserved T cell subtypes, providing a stable basis for describing T cell heterogeneity consistently across different diseases and species.
NATURE COMMUNICATIONS
(2021)
Article
Cell Biology
Jernej Pusnik et al.
Summary: Memory B cells specific to the spike protein of SARS-CoV-2 are generated in smaller numbers but with superior function in individuals recovering from mild COVID-19, dependent on IL-21(+)CD4(+) T cells. In contrast, severely ill COVID-19 patients generate fewer efficient memory B cells with dependence on CD40L(+)CD4(+) T cells. Activation and exhaustion of memory B cells during COVID-19 are linked to CD4(+) T cell functions, with CD4(+) T cells recognizing membrane proteins showing stronger association with spike-specific memory B cells.
Article
Immunology
Danrong Shi et al.
Summary: The study found that antibodies produced after COVID-19 infection can remain detectable and effective for over a year, with different antibodies showing varied reactions over time.
FRONTIERS IN IMMUNOLOGY
(2021)
Letter
Cell Biology
Furong Qi et al.
Article
Cell Biology
Qiqi Cao et al.
Summary: COVID-19, caused by SARS-CoV-2, is a severe global health threat, with vaccines being highly effective in combating it. By using scRNA/V(D)J-seq technology to study peripheral blood mononuclear cells from COVID-19 vaccine trial participants longitudinally, enhanced immune responses were observed, providing insights for assessing vaccine efficacy.
Article
Immunology
Samuele Notarbartolo et al.
Summary: This study describes the development of immunity against SARS-CoV-2 and identifies an effector CD8(+) T cell population with memory precursor-like features.
SCIENCE IMMUNOLOGY
(2021)
Article
Immunology
Julia Niessl et al.
Summary: The study found that in individuals who had not been exposed to SARS-CoV-2, the frequencies of SARS-CoV-2-specific memory CD4(+) T cells were similar in tonsils and peripheral blood, but functional SARS-CoV-2-specific memory CD8(+) T cells were mostly found in tonsils. This suggests that preexisting tissue-resident memory CD8(+) T cells in unexposed individuals could potentially mount rapid immune responses against SARS-CoV-2.
SCIENCE IMMUNOLOGY
(2021)
Article
Biochemistry & Molecular Biology
Bing He et al.
Summary: This study revealed the frequency, diversity, and specificity of antibody immune responses following SARS-CoV-2 infection using the LIBRA-seq technology. The results showed that a specific memory B cell subgroup in convalescent COVID-19 patients had a higher proportion of SARS-CoV-2 antigen-labeled cells, and public antibody clonotypes were shared by distinct individuals. Additionally, antibodies isolated by LIBRA-seq exhibited high binding affinity and neutralizing activities against SARS-CoV-2.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2021)
Review
Immunology
Peter C. Taylor et al.
Summary: The study discusses the clinical utility of neutralizing monoclonal antibody therapies targeting SARS-CoV-2, emphasizing the importance of patient stratification, biomarkers, risk factors, and other clinical considerations.
NATURE REVIEWS IMMUNOLOGY
(2021)
Article
Cell Biology
Alison Tarke et al.
Summary: By studying T cell responses in 99 convalescent COVID-19 cases, we identified various HLA-restricted epitopes derived from SARS-CoV-2 and observed distinct patterns of immunodominance. The epitopes were combined into megapools to facilitate the identification and quantification of virus-specific CD4(+) and CD8(+) T cells.
CELL REPORTS MEDICINE
(2021)
Article
Biochemistry & Molecular Biology
Isabel Schulien et al.
Summary: The study found that SARS-CoV-2 infection induces and forms functionally competent memory CD8(+) T cell responses, which can persist in some SARS-CoV-2 convalescent individuals. Even in the absence of virus-specific antibodies, these virus epitope-specific CD8(+) T cell responses are induced following infection.
Article
Physiology
Wen Shi et al.
Summary: This study utilized single-cell mass cytometry to explore the peripheral cellular profiles of COVID-19 patients, revealing alterations in immune cell subsets, including CD4(+) T-cell depletion and dysregulation of monocyte populations induced by the virus.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
(2021)
Review
Immunology
Amanda Ardain et al.
Article
Biochemistry & Molecular Biology
Alba Grifoni et al.
Article
Biochemistry & Molecular Biology
Pierre Bost et al.
Article
Multidisciplinary Sciences
Bin Ju et al.
Article
Cell Biology
Wen Wen et al.
Article
Biochemistry & Molecular Biology
Mingfeng Liao et al.
Article
Biochemistry & Molecular Biology
Yunlong Cao et al.
Article
Immunology
Linnan Zhu et al.
Article
Immunology
Daniela Weiskopf et al.
SCIENCE IMMUNOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Naoki Kaneko et al.
Article
Biochemistry & Molecular Biology
Benjamin J. Meckiff et al.
Letter
Immunology
Barbara Oliviero et al.
CELLULAR & MOLECULAR IMMUNOLOGY
(2020)
Article
Multidisciplinary Sciences
Nina Le Bert et al.
Article
Immunology
Ji-Yuan Zhang et al.
Article
Biochemistry & Molecular Biology
Aaron J. Wilk et al.
Article
Multidisciplinary Sciences
Divij Mathew et al.
Article
Multidisciplinary Sciences
Jerome Hadjadj et al.
Article
Multidisciplinary Sciences
Zhe Lv et al.
Article
Cell Biology
Yingfeng Zheng et al.
Article
Immunology
Matthew C. Woodruff et al.
Article
Immunology
Yanchun Peng et al.
Article
Multidisciplinary Sciences
Prabhu S. Arunachalam et al.
Article
Immunology
Bahire Kalfaoglu et al.
FRONTIERS IN IMMUNOLOGY
(2020)
Article
Cell Biology
Gang Xu et al.
Article
Biochemistry & Molecular Biology
Yapeng Su et al.
Article
Immunology
Petra Bacher et al.
Article
Immunology
Joana P. Bernardes et al.
Article
Immunology
Alina S. Shomuradova et al.
Article
Immunology
Victor A. Sosa-Hernandez et al.
FRONTIERS IN IMMUNOLOGY
(2020)
Article
Cell Biology
Jason Neidleman et al.
CELL REPORTS MEDICINE
(2020)
Review
Immunology
Alex D. Waldman et al.
NATURE REVIEWS IMMUNOLOGY
(2020)
Review
Immunology
Lilit Grigoryan et al.
SEMINARS IN IMMUNOLOGY
(2020)
Article
Immunology
Zeyu Chen et al.
NATURE REVIEWS IMMUNOLOGY
(2020)
Review
Immunology
Munir Akkaya et al.
NATURE REVIEWS IMMUNOLOGY
(2020)
Article
Biochemistry & Molecular Biology
Maria Carolina Amezcua Vesely et al.
Article
Multidisciplinary Sciences
Nicholas J. Maurice et al.
NATURE COMMUNICATIONS
(2019)
Review
Immunology
Haoyu Sun et al.
CELLULAR & MOLECULAR IMMUNOLOGY
(2019)
Article
Biochemistry & Molecular Biology
Ian Setliff et al.
Review
Immunology
Brahma V. Kumar et al.
Article
Multidisciplinary Sciences
Lei Zhang et al.
Review
Immunology
Luka Mesin et al.
Review
Immunology
Michel DuPage et al.
NATURE REVIEWS IMMUNOLOGY
(2016)
Article
Immunology
Shreemanta K. Parida et al.
CLINICAL INFECTIOUS DISEASES
(2015)
Article
Hematology
Lucinda J. Berglund et al.
Review
Immunology
P. Anton van der Merwe et al.
NATURE REVIEWS IMMUNOLOGY
(2011)
Review
Immunology
David L. Woodland et al.
NATURE REVIEWS IMMUNOLOGY
(2009)
Article
Immunology
Stephen L. Nutt et al.
NATURE REVIEWS IMMUNOLOGY
(2007)
